BSX vs STE
BSX: Boston Scientific is a leading medical technology company delivering minimally invasive interventional solutions to improve patient health across diverse clinical specialties. STE: STERIS is a global provider of infection prevention and procedural care products and services that help healthcare and life science organizations create a safer, healthier world.
Side-by-side fundamentals
| Metric | BSX | STE | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $42.97 | $210.57 | |
| Market cap as of 2026-07-23 | $63.7B | $20.6B | |
| P/E as of 2026-07-23 | 17.88 | 26.28 | BSX lower |
| PEG as of 2026-07-23 | 0.24 | 1.00 | BSX lower |
| Net margin as of 2026-07-23 | +17.3% | +13.2% | BSX higher |
| Gross margin as of 2026-07-23 | +69.1% | +44.3% | BSX higher |
| Operating margin as of 2026-07-23 | +18.4% | +18.5% | STE higher |
| ROE as of 2026-07-23 | +14.9% | +11.1% | BSX higher |
| ROA as of 2026-07-23 | +8.3% | +7.4% | BSX higher |
| Debt / equity as of 2026-07-23 | 0.43 | 0.27 | STE lower |
| Revenue growth (YoY) as of 2026-07-23 | +17.4% | +8.7% | BSX higher |
| Revenue CAGR (3y) SEC XBRL | +16.5% | +9.4% | BSX higher |
| Dividend yield as of 2026-07-23 | +0.0% | +1.2% | STE higher |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-23 | 0.58 | 0.93 | |
| 1-year return as of 2026-07-22 close | -58.3% | -5.9% | STE higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.